ADVIA Centaur

Fabricante

  • Empresa matriz del fabricante (2017)
  • Comentario del fabricante
    Note published by the authorities from the Netherlands: This message is a warning from the manufacturer. After placing a medical device on the market, the manufacturer is obliged to follow the device and, where necessary, to improve it. When there is a risk for the user, the manufacturer must take action. The manufacturer informs users and the inspection of this action with a warning (Field Safety Notice). See also medical device warnings. This is part of the supervision of medical technology.
  • Source
    IGJ

797 dispositivos con un nombre similar

Más información acerca de la data acá

  • Modelo / Serial
    Lot Code: 144 Affected kit lot numbers: 62431144, 63124144, 63519144, 63876144, 62450144 and 63822144 Expiry Date: 15 September 2011
  • Clasificación del producto
  • Clase de dispositivo
    2
  • ¿Implante?
    No
  • Distribución
    Worldwide distribution, including USA, Canada, Argentina, Austria, Belgium, China, Denmark, France, Germany, Great Britain, Greece, India, Italy, Japan, Korea, Lavitia, Lithuania, Malyasia, Mexico, Netherlands, Norway, Peru, Philippines, Poland, Portugal, Romania, Saudi Arabia, Switzerland, Serbia, Singapore, Slovakia, South Africa, Spain, Sweden, Czech Republic, Taiwan, Turkey, Uganda, and Venezuela
  • Descripción del producto
    ADVIA Centaur CA 125 II Assay packaged in 100 and 500 test kits as follows: || Product code: 09427226 (128532) 100 test kit || Product code: 01678114 (128533) 500 Test kit
  • Manufacturer
792 más